These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3698407)

  • 1. [Effect of pulse therapy on delayed contrast-enhancing CT scan lesion in a patient with multiple sclerosis].
    Konishi T; Saida T; Nishitani H
    Rinsho Shinkeigaku; 1986 Jan; 26(1):71-5. PubMed ID: 3698407
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis.
    Troiano R; Hafstein M; Ruderman M; Dowling P; Cook S
    Ann Neurol; 1984 Mar; 15(3):257-63. PubMed ID: 6721447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polarizing solutions and intrathecal methylprednisolone acetate in therapy of multiple sclerosis: preliminary study.
    De Vito SJ; Mannarelli AA
    J Am Osteopath Assoc; 1966 Mar; 65(7):713-22. PubMed ID: 5175985
    [No Abstract]   [Full Text] [Related]  

  • 4. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.
    Durelli L; Baggio GF; Bergamasco B; Barile C; Cocito D; Delsedime M; Perla F; Riccio A; Bergamini L
    Acta Neurol (Napoli); 1985; 7(3-4):338-44. PubMed ID: 3904340
    [No Abstract]   [Full Text] [Related]  

  • 5. [Promising results with methylprednisolone in multiple sclerosis. Lack of patent rights makes drug industry less interested].
    Kling A; Dahlqvist R
    Lakartidningen; 2007 Jan 17-23; 104(3):128-30. PubMed ID: 17302117
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of methylprednisolone-pulse therapy on superoxide production of neutrophils.
    Yoshida T; Tanaka M; Sotomatsu A; Okamoto K
    Neurol Res; 1999 Jul; 21(5):509-12. PubMed ID: 10439433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple sclerosis. Clinico-statistical results of therapy based on intrathecal methylprednisolone acetate].
    Sbarbaro V; Girelli Bruni E; Monaco V; Gasperini GF; Zardini GB; Brogi L
    Minerva Med; 1974 Sep; 65(65):3407-11. PubMed ID: 4479023
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. I. Clinical results].
    Hanák L; Zouhar A
    Cesk Neurol Neurochir; 1974 Sep; 37(5):287-92. PubMed ID: 4479028
    [No Abstract]   [Full Text] [Related]  

  • 9. Polarizing solution and intrathecal methylprednisolone acetate in multiple sclerosis: follow-up study.
    Beck RH
    J Am Osteopath Assoc; 1967 Feb; 66(6):664-6. PubMed ID: 5182604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebral venous thrombosis after lumbar puncture and intravenous steroids in two patients with multiple sclerosis].
    Städler C; Vuadens P; Dewarrat A; Janzer R; Uske A; Bogousslavsky J
    Rev Neurol (Paris); 2000 Feb; 156(2):155-9. PubMed ID: 10743014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal methylprednisolone acetate in multiple sclerosis treatment. Clinical evaluation.
    Mazzarello P; Poloni M; Piccolo G; Cosi V; Pinelli P
    Acta Neurol Belg; 1983; 83(4):190-6. PubMed ID: 6689244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential computed tomography and 123I-HIPDM scans in multiple sclerosis with large plaque. A case report.
    Pozzilli C; Pantano P; Bozzao L; Bernardi S; Carolei A; Fieschi C
    Eur Neurol; 1987; 27(2):88-91. PubMed ID: 3497807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of multiple sclerosis with pathological laughing caused by pontine base lesions].
    Takado Y; Igarashi S; Akaiwa Y; Terajima K; Tanaka K; Tsuji S
    Rinsho Shinkeigaku; 2002 Jun; 42(6):519-22. PubMed ID: 12607978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CT with high-dose contrast medium administration and delayed conduction and NMR tomography in the diagnosis of multiple sclerosis].
    Hornig CR; Busse O; Dorndorf W; Kaps M; Schütz HJ; Broschek P; Agnoli AL; Meves M; Rinck PA
    Nervenarzt; 1984 Aug; 55(8):419-21. PubMed ID: 6483063
    [No Abstract]   [Full Text] [Related]  

  • 15. [Course of multiple sclerosis with and without corticosteroid therapy].
    Schergna E; Tonin P
    Riv Neurol; 1981; 51(6):322-9. PubMed ID: 7336086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allergic skin rashes by methylprednisolone in a case with multiple sclerosis].
    Kuga A; Futamura N; Funakawa I; Jinnai K
    Rinsho Shinkeigaku; 2004 Oct; 44(10):691-4. PubMed ID: 15568486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. II. Results in cerebrospinal fluid].
    Hrazdira CL; Mandzjuk B; Skálová M
    Cesk Neurol Neurochir; 1974 Sep; 37(5):293-300. PubMed ID: 4479029
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.
    Smith D
    J Neurol Sci; 2004 Aug; 223(1):73-9. PubMed ID: 15261565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.
    Diem R; Sättler MB; Merkler D; Demmer I; Maier K; Stadelmann C; Ehrenreich H; Bähr M
    Brain; 2005 Feb; 128(Pt 2):375-85. PubMed ID: 15601662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocardia brain stem abscess: diagnosis and response to medical therapy.
    Bertoldi RV; Sperling MR
    Bull Clin Neurosci; 1984; 49():99-104. PubMed ID: 6100784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.